Dendritic Cell Surface Calreticulin Is a Receptor for NY-ESO-1: Direct Interactions between Tumor-Associated Antigen and the Innate Immune System1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Immunology

• Publication date

  2006-09-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.177.6.3582PMID 16951317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.

  2005cited by this paper
• Surface Calreticulin Mediates Muramyl Dipeptide-induced Apoptosis in RK13 Cells*

  2005cited by this paper
• IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation.

  2004cited by this paper
• By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

  2003cited by this paper
• Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

  2003cited by this paper
• ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

  2003cited by this paper
• Maturation-dependent expression of C1q binding proteins on the cell surface of human monocyte-derived dendritic cells.

  2003cited by this paper
• Molecular identification of a danger signal that alerts the immune system to dying cells

  2003cited by this paper
• Maturation-dependent expression of C1q-binding proteins on the cell surface of human monocyte-derived dendritic cells.

  2003cited by this paper
• Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

  2002cited by this paper
• Tumor‐specific shared antigenic peptides recognized by human T cells

  2002cited by this paper
• Decoding the Patterns of Self and Nonself by the Innate Immune System

  2002cited by this paper
• Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.

  2002cited by this paper
• Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex1

  2002cited by this paper
• CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

  2001cited by this paper
• CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

  2001cited by this paper
• The Interaction of FcαRI with IgA and Its Implications for Ligand Binding by Immunoreceptors of the Leukocyte Receptor Cluster1

  2001cited by this paper
• C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells

  2001cited by this paper
• Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

  2000cited by this paper
• Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

  2000cited by this paper
• Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes

  2000cited by this paper
• Setting the standards: quality control in the secretory pathway.

  1999cited by this paper
• The nature of the MHC class I peptide loading complex

  1999cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations.

  1997cited by this paper
• A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.

  1997cited by this paper
• Quality control in the secretory pathway.

  1995cited by this paper
• Tolerance, danger, and the extended family.

  1994cited by this paper

• NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy

  2024cites this paper
• Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy

  2024cites this paper
• Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients

  2023cites this paper
• Photon- and Proton-Mediated Biological Effects: What Has Been Learned?

  2022cites this paper
• Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies

  2021cites this paper
• Calreticulin Blockade Attenuates Murine Acute Lung Injury by Inducing Polarization of M2 Subtype Macrophages

  2020cites this paper
• Immunogenicity and cytotoxicity of a platinum(IV) complex derived from capsaicin.

  2020cites this paper
• Autoantibody in Cancer

  2019cites this paper
• Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer.

  2018cites this paper
• Encéphalites à anticorps anti-NMDAR : étude clinique et mécanistique

  2017cites this paper
• Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.

  2017cites this paper
• A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

  2017cites this paper
• Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin)

  2016cites this paper
• Damage-associated molecular patterns in cancer: A double-edged sword

  2016cites this paper
• Calreticulin, a therapeutic target?

  2016cites this paper
• Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation

  2015cites this paper
• Dendritic cell activation and maturation induced by recombinant calreticulin fragment 39-272.

  2015cites this paper
• Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer

  2015cites this paper
• A Genetic Vaccine encoding Chimeric NY-ESO-1 induces Anticancer Immunity in a Mouse Model

  2015cites this paper
• Bilateral acute pyogenic conjunctivitis with iritis induced by unilateral topical application of bacterial peptidoglycan muramyl dipeptide in adult rabbits.

  2013cites this paper
• Enhancing Whole-Tumor Cell Vaccination by Engaging Innate Immune System Through NY-ESO-1/Dendritic Cell Interactions

  2013cites this paper
• The pathogenesis of oxaliplatin induced sinusoidal obstruction syndrome

  2013cites this paper
• Bee Venom Phospholipase A2, a Good “Chauffeur” for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1

  2013cites this paper
• Enolase 1 and calreticulin regulate the differentiation and function of mouse mast cells.

  2012cites this paper
• Calreticulin as a potential diagnostic biomarker for lung cancer

  2012cites this paper
• Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?

  2012cites this paper
• Calreticulin as a potential diagnostic biomarker for lung cancer

  2012cites this paper
• Modulation of cellular immunity by antibodies against calreticulin

  2012cites this paper
• Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy

  2012cites this paper
• New insights into the functional role of the rheumatoid arthritis shared epitope

  2011cites this paper
• Poly(ADP-ribosyl)ation of mannose-binding lectin out of human kidney cells

  2011cites this paper
• Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization

  2011cites this paper
• Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

  2011cites this paper
• Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

  2011cites this paper
• The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination.

  2011cites this paper
• Polymeric Structure and Host Toll-like Receptor 4 Dictate Immunogenicity of NY-ESO-1 Antigen in Vivo*

  2011cites this paper
• Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity

  2011cites this paper
• Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies

  2011cites this paper
• Immunogénicite de la mort cellulaire induite par les chimiothérapies anti-cancéreuses

  2011cites this paper
• T‐cell expression of CD91 – a marker of unresponsiveness to anti‐TNF therapy in rheumatoid arthritis

  2010cites this paper
• Immunogenic death of colon cancer cells treated with oxaliplatin

  2010cites this paper
• Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.

  2010cites this paper
• Calreticulin in Health and Disease for Immunobiological Activities of 272: Implications - Calreticulin Fragment 39 Functional Analysis of Recombinant

  2010cites this paper
• Calreticulin: non‐endoplasmic reticulum functions in physiology and disease

  2010cites this paper
• Functional Analysis of Recombinant Calreticulin Fragment 39–272: Implications for Immunobiological Activities of Calreticulin in Health and Disease

  2010cites this paper
• This information is current as Arthritis Shared Epitope Immune Dysregulation by the Rheumatoid

  2010cites this paper
• A role for calreticulin in the pathogenesis of rheumatoid arthritis

  2010cites this paper
• Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.

  2010cites this paper
• Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.

  2010cites this paper
• Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum.

  2009cites this paper
• Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response

  2009cites this paper
• Endogenous Jmjd6 gene product is expressed at the cell surface and regulates phagocytosis in immature monocyte‐like activated THP‐1 cells

  2009cites this paper
• C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells.

  2009cites this paper
• C1q enhances IFN- (cid:1) production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells

  2009cites this paper
• Antigenic stimulation with cytochrome P450 2J expressed in mouse hepatocellular carcinoma cells regulates host anti‐tumour immunity

  2009cites this paper
• C1q enhances IFN-γ production by antigen specific T cells via the CD40 co-stimulatory pathway on dendritic cells

  2008cites this paper
• Cancer Immunology

  2008cites this paper
• New Roles for Mononuclear Phagocytes in Cancer Biology

  2008cites this paper
• From regulation of dying cell engulfment to development of anti-cancer therapy

  2008cites this paper
• Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference

  2007influential citation
• Identification of a Novel Cancer-Testis Antigen CRT2 Frequently Expressed in Various Cancers Using Representational Differential Analysis

  2007cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper
• With Broad Antigen Specificity T Cell Responses + and Cd4 + Human Cd8 Receptor or Dec-205 in Vitro Elicits Dual Antibody-targeted Ny-eso-1 to Mannose

  year unknowncites this paper